Back to Search
Orsythia
by Endo Operations LtdContraceptionCOCP
DiscontinuedGeneric

Estrogen

Ethinyl Estradiol

0.02Mg

Progestin

Levonorgestrel

0.1Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

High

Approval Date

5/11/2011

Additives
None
Inactive Ingredients
lactose monohydratelactose anhydrouspregelatinized starchcorn starchcrospovidonemagnesium stearatepovidoneFD&C Red # 40 lakeD&C Yellow #10 lake

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Aurobindo Pharma Limited

Afirmelle

Afaxys Pharma

Aubra

Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc

Aviane-28

Avion Pharmaceuticals

Balcoltra

Bayer

Delyla

Northstar Rx LLC

Falmina

Barr Laboratories Inc

Lessina-28

Dr Reddys Laboratories Sa

Levonorgestrel And Ethinyl Estradiol
Levonorgestrel And Ethinyl Estradiol

Hetero Labs Ltd

Levonorgestrel And Ethinyl Estradiol

Lupin Ltd

Levonorgestrel And Ethinyl Estradiol

Naari Pte Ltd

Levonorgestrel And Ethinyl Estradiol

Xiromed Llc

Levonorgestrel And Ethinyl Estradiol

Xiromed Pharma Espana Sl

Levonorgestrel And Ethinyl Estradiol And Ferrous Fumarate

Mayne Pharma Inc.

Lutera

Lupin Pharmaceuticals, Inc.

Minzoya

Dr. Reddy's Labratories Inc.

Sronyx

Exeltis USA, Inc.

Tyblume

Xiromed, LLC.

Vienva

Have clinical questions about Orsythia?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy